Geodon, for schizophrenia, is growing quickly as newer schizophrenia drugs steal market share from Zyprexa, from Eli Lilly (nyse: LLY - news - people ), largely due to concernsoversideeffects such as weight gain.
But the FDA has been very cautious before finally issuing approval for these two drugs, citing concernsover potential sideeffects and consumers who may lobby physicians unnecessarily for prescriptions.
The generic is Budeprion XL 300, and concernsover its effectiveness date back to 2007 when patients started complaining of multiple sideeffects, including headaches, anxiety and insomnia.